Correction to “HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study” - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum for “HLA-B Correlates With Unique Disease Manifestations in Juvenile Spondyloarthritis: A Retrospective Cohort Analysis”

  • September 15, 2026

Share

Objective:

To correct a typesetting error in the published article regarding HLA-B and juvenile spondyloarthritis.

Approach:
  • Correction: The erratum addresses a typesetting error in Table 2 of the Results section, specifically the incorrect assignment of superscript 'c'.
Key Findings:
  • The superscript 'c' should be deleted from the value corresponding to B*18:01 and IBD-AA.
  • The superscript 'c' should be assigned to the value corresponding to B*35:02 and IBD-AA.
Interpretation:

The error did not appear in the authors’ revised manuscript and was overlooked during proof review.

Limitations:
  • The typesetting error may have led to confusion regarding the data presented in Table 2.
Conclusion:

The authors regret the error.

Sources:

Original Source(s)

Correction to “HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study”

  • September 15, 2026

Related Content

Spondyloarthritis Research and Treatment Network Recommendations for the Referral of Adults With Chronic Back Pain and Suspected Axial Spondyloarthritis to a Rheumatologist

CD19 CAR T Therapy Tested in Refractory Rheumatoid Arthritis

Disease activity fell in all six participants in a phase I trial, with three achieving sustained drug-free remission during follow-up

  • September 8, 2026

  • 3 min
Menopause may be underdocumented in EHRs

Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.